Terms: = Germ cell tumor AND CTCF, P49711, 10664, ENSG00000102974
49 results:
1. Modeling epigenetic lesions that cause gliomas.
Rahme GJ; Javed NM; Puorro KL; Xin S; Hovestadt V; Johnstone SE; Bernstein BE
Cell; 2023 Aug; 186(17):3674-3685.e14. PubMed ID: 37494934
[TBL] [Abstract] [Full Text] [Related]
2. 3D genome mapping identifies subgroup-specific chromosome conformations and tumor-dependency genes in ependymoma.
Okonechnikov K; Camgöz A; Chapman O; Wani S; Park DE; Hübner JM; Chakraborty A; Pagadala M; Bump R; Chandran S; Kraft K; Acuna-Hidalgo R; Reid D; Sikkink K; Mauermann M; Juarez EF; Jenseit A; Robinson JT; Pajtler KW; Milde T; Jäger N; Fiesel P; Morgan L; Sridhar S; Coufal NG; Levy M; Malicki D; Hobbs C; Kingsmore S; Nahas S; Snuderl M; Crawford J; Wechsler-Reya RJ; Davidson TB; Cotter J; Michaiel G; Fleischhack G; Mundlos S; Schmitt A; Carter H; Michealraj KA; Kumar SA; Taylor MD; Rich J; Buchholz F; Mesirov JP; Pfister SM; Ay F; Dixon JR; Kool M; Chavez L
Nat Commun; 2023 Apr; 14(1):2300. PubMed ID: 37085539
[TBL] [Abstract] [Full Text] [Related]
3. Promoter and enhancer RNAs regulate chromatin reorganization and activation of miR-10b/HOXD locus, and neoplastic transformation in glioma.
Deforzh E; Uhlmann EJ; Das E; Galitsyna A; Arora R; Saravanan H; Rabinovsky R; Wirawan AD; Teplyuk NM; El Fatimy R; Perumalla S; Jairam A; Wei Z; Mirny L; Krichevsky AM
Mol Cell; 2022 May; 82(10):1894-1908.e5. PubMed ID: 35390275
[TBL] [Abstract] [Full Text] [Related]
4. Data mining of bulk and single-cell RNA sequencing introduces OBI1-AS1 as an astrocyte marker with possible role in glioma recurrence and progression.
Mamivand A; Bayat S; Maghrouni A; Shabani S; Khoshnevisan A; Saffar H; Tabrizi M
Clin Epigenetics; 2022 Mar; 14(1):35. PubMed ID: 35260196
[TBL] [Abstract] [Full Text] [Related]
5. KDM6B promotes activation of the oncogenic CDK4/6-pRB-E2F pathway by maintaining enhancer activity in MYCN-amplified neuroblastoma.
D'Oto A; Fang J; Jin H; Xu B; Singh S; Mullasseril A; Jones V; Abu-Zaid A; von Buttlar X; Cooke B; Hu D; Shohet J; Murphy AJ; Davidoff AM; Yang J
Nat Commun; 2021 Dec; 12(1):7204. PubMed ID: 34893606
[TBL] [Abstract] [Full Text] [Related]
6. BORIS/ctcfL expression activates the TGFβ signaling cascade and induces Drp1 mediated mitochondrial fission in neuroblastoma.
Makani VKK; Mendonza JJ; Edathara PM; Yerramsetty S; Pal Bhadra M
Free Radic Biol Med; 2021 Nov; 176():62-72. PubMed ID: 34534628
[TBL] [Abstract] [Full Text] [Related]
7. ctcf binding modulates UV damage formation to promote mutation hot spots in melanoma.
Sivapragasam S; Stark B; Albrecht AV; Bohm KA; Mao P; Emehiser RG; Roberts SA; Hrdlicka PJ; Poon GMK; Wyrick JJ
EMBO J; 2021 Oct; 40(20):e107795. PubMed ID: 34487363
[TBL] [Abstract] [Full Text] [Related]
8. Mechanisms of TP53 Pathway Inactivation in Embryonic and Somatic cells-Relevance for Understanding (germ cell) tumorigenesis.
Timmerman DM; Remmers TL; Hillenius S; Looijenga LHJ
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065345
[TBL] [Abstract] [Full Text] [Related]
9. Genomic Space of
Ibrahim Al-Obaide MA; Arutla V; Bacolod MD; Wang W; Zhang R; Srivenugopal KS
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33801310
[TBL] [Abstract] [Full Text] [Related]
10. Decreased Expression of CPEB3 Predicts a Poor Prognosis in Patients with Melanoma: A Study Based on TCGA Data.
Zhang X; Liang Y
Biomed Res Int; 2021; 2021():8197936. PubMed ID: 33506034
[TBL] [Abstract] [Full Text] [Related]
11. DNA hypermethylation/boundary control loss identified in retinoblastomas associated with genetic and epigenetic inactivation of the
Raizis AM; Racher HM; Foucal A; Dimaras H; Gallie BL; George PM
Epigenetics; 2021 Sep; 16(9):940-954. PubMed ID: 33258708
[TBL] [Abstract] [Full Text] [Related]
12. Generation of onco-enhancer enhances chromosomal remodeling and accelerates tumorigenesis.
Chai P; Yu J; Jia R; Wen X; Ding T; Zhang X; Ni H; Jia R; Ge S; Zhang H; Fan X
Nucleic Acids Res; 2020 Dec; 48(21):12135-12150. PubMed ID: 33196849
[TBL] [Abstract] [Full Text] [Related]
13. Hypermethylation and global remodelling of DNA methylation is associated with acquired cisplatin resistance in testicular germ cell tumours.
Fazal Z; Singh R; Fang F; Bikorimana E; Baldwin H; Corbet A; Tomlin M; Yerby C; Adra N; Albany C; Lee S; Freemantle SJ; Nephew KP; Christensen BC; Spinella MJ
Epigenetics; 2021 Oct; 16(10):1071-1084. PubMed ID: 33126827
[TBL] [Abstract] [Full Text] [Related]
14. Correlative study of epigenetic regulation of tumor microenvironment in spindle cell melanomas and cutaneous malignant peripheral nerve sheath tumors.
Vougiouklakis T; Aung PP; Vasudevaraja V; Prieto VG; Torres-Cabala CA; Sulman EP; Snuderl M; Jour G
Sci Rep; 2020 Aug; 10(1):12996. PubMed ID: 32747660
[TBL] [Abstract] [Full Text] [Related]
15. HNF4A-AS1/hnRNPU/ctcf axis as a therapeutic target for aerobic glycolysis and neuroblastoma progression.
Song H; Li D; Wang X; Fang E; Yang F; Hu A; Wang J; Guo Y; Liu Y; Li H; Chen Y; Huang K; Zheng L; Tong Q
J Hematol Oncol; 2020 Mar; 13(1):24. PubMed ID: 32216806
[TBL] [Abstract] [Full Text] [Related]
16. BORIS promotes chromatin regulatory interactions in treatment-resistant cancer cells.
Debruyne DN; Dries R; Sengupta S; Seruggia D; Gao Y; Sharma B; Huang H; Moreau L; McLane M; Day DS; Marco E; Chen T; Gray NS; Wong KK; Orkin SH; Yuan GC; Young RA; George RE
Nature; 2019 Aug; 572(7771):676-680. PubMed ID: 31391581
[TBL] [Abstract] [Full Text] [Related]
17. Chromatin loop anchors are associated with genome instability in cancer and recombination hotspots in the germline.
Kaiser VB; Semple CA
Genome Biol; 2018 Jul; 19(1):101. PubMed ID: 30060743
[TBL] [Abstract] [Full Text] [Related]
18. Disruption of a -35 kb Enhancer Impairs ctcf Binding and
Liu Q; Thoms JAI; Nunez AC; Huang Y; Knezevic K; Packham D; Poulos RC; Williams R; Beck D; Hawkins NJ; Ward RL; Wong JWH; Hesson LB; Sloane MA; Pimanda JE
Clin Cancer Res; 2018 Sep; 24(18):4602-4611. PubMed ID: 29898989
[No Abstract] [Full Text] [Related]
19. Bivalent Chromatin Domains in Glioblastoma Reveal a Subtype-Specific Signature of Glioma Stem cells.
Hall AW; Battenhouse AM; Shivram H; Morris AR; Cowperthwaite MC; Shpak M; Iyer VR
Cancer Res; 2018 May; 78(10):2463-2474. PubMed ID: 29549165
[TBL] [Abstract] [Full Text] [Related]
20. Risk-Associated Long Noncoding RNA FOXD3-AS1 Inhibits Neuroblastoma Progression by Repressing PARP1-Mediated Activation of ctcf.
Zhao X; Li D; Huang D; Song H; Mei H; Fang E; Wang X; Yang F; Zheng L; Huang K; Tong Q
Mol Ther; 2018 Mar; 26(3):755-773. PubMed ID: 29398485
[TBL] [Abstract] [Full Text] [Related]
[Next]
